arrow
E

Eugen Mengel

Baylor University Medical Center
H指数:14
被引数:1,118

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial

Arimoclomol在尼曼-皮克病C型中的长期疗效与安全性:NPC-002 48个月开放标签扩展试验2/3期的最终结果

2025-07-070
PRE
Trappsol® CycloTM (hpβCd) for the long-term treatment of Niemann Pick type C1: Efficacy and safety data from 4 clinical studies and the ongoing expanded access program
2025-02-010
PRE
Trial of N-Acetyl-L-Leucine in Niemann-Pick Disease Type C
2024-02-018
PRE
Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C
2024-02-010
PRE
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
2022-08-0224
OAAI
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study (vol 15, 328, 2020)
2021-06-011
OAAI
NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in participants with late-onset pompe disease (LOPD)
2021-02-011
PREAI
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study
2020-11-2315
OAAI
NEO1 and NEO-EXT studies: Long-term safety and exploratory efficacy of repeat avalglucosidase alfa dosing for 5.5 years in late-onset Pompe disease patients
2020-02-015
PREAI